Taylor Andrew Lawrence
Known title: Chief Financial OfficerCIK: 0001723889
Taylor Andrew Lawrence's purchase track record
Taylor Andrew Lawrence has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/25/2025 | OBIO | $5K | +86.2% | +55.0% | +6.2% |
| 12/19/2024 | OBIO | $5K | -9.4% | -37.3% | +1.7% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| OBIO | ▼ Sell | Tax Withholding | 3,076 | $16K | 8/26/2026 | View on chart |
| OBIO | ▼ Sell | Tax Withholding | 36,352 | $146K | 6/10/2026 | View on chart |
| OBIO | ▼ Sell | Tax Withholding | 3,076 | $12K | 5/28/2026 | View on chart |
| OBIO | ▲ Buy | Grant | 181,000 | $0 | 2/12/2026 | View on chart |
| OBIO | ▼ Sell | Tax Withholding | 3,452 | $15K | 1/2/2026 | View on chart |
| OBIO | ▼ Sell | Tax Withholding | 8,670 | $40K | 12/10/2025 | View on chart |
| OBIO | ▼ Sell | Tax Withholding | 3,071 | $16K | 11/25/2025 | View on chart |
| OBIO | ▼ Sell | Tax Withholding | 16,102 | $40K | 9/17/2025 | View on chart |
| OBIO | ▲ Buy | Open Market | 2,000 | $5K | 8/25/2025 | View on chart |
| OBIO | ▲ Buy | Grant | 80,000 | $0 | 8/7/2025 | View on chart |
| OBIO | ▼ Sell | Tax Withholding | 28,172 | $88K | 6/11/2025 | View on chart |
| OBIO | ▲ Buy | Grant | 84,000 | $0 | 4/4/2025 | View on chart |
| OBIO | ▲ Buy | Open Market | 1,000 | $5K | 12/19/2024 | View on chart |
| OBIO | ▼ Sell | Tax Withholding | 34,403 | $173K | 12/12/2024 | View on chart |
| OBIO | ▲ Buy | Grant | 100,000 | $0 | 5/8/2024 | View on chart |
| OBIO | ▲ Buy | Grant | 278,363 | $0 | 7/20/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
OBIO Shares Rise 5.2% Amid Positive Momentum
Orchestra BioMed Holdings (OBIO) shares recently increased by 5.2%, a move that some observers see as a sign of strengthening momentum. The stock currently trades within its 52-week range of $2.20 to $6.48. Analysts maintain an average price target of $12.14, suggesting a significant gap between the current market price and professional estimates.
OBIO Shares Rise 5.2% Amid Positive Momentum. Orchestra BioMed Holdings (OBIO) shares recently increased by 5.2%, a move that some observers see as a sign of strengthening momentum. The stock currently trades within its 52-week range of $2.20 to $6.48. Analysts maintain an average price target of $12.14, suggesting a significant gap between the current market price and professional estimates.